David Hou Awarded 2022 ABTA Lucien Rubinstein Award for ‘B Cell Vaccine Promotes Anti-Glioma Immunity Through Modulating CD8+ T Cells’
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
